The Virtual Meeting provided insights into identified challenges of diagnosis and treatment of patients with NSCLC, harboring EGFR exon 20 insertion mutations based on the view of experts from Austria, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Hungary, Latvia, Romania, Serbia, and Slovenia. Here, EGFR is linked to non-small cell lung carcinoma.